rolipram has been researched along with Anterior Cerebral Circulation Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wan, D | 1 |
| Zhou, Y | 1 |
| Wang, K | 1 |
| Hou, Y | 1 |
| Hou, R | 1 |
| Ye, X | 1 |
1 other study available for rolipram and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Brain; Brain Infarction; Cyclic AMP; | 2016 |